Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial) – A phase II non-randomised trial
2014; Elsevier BV; Volume: 50; Issue: 18 Linguagem: Inglês
10.1016/j.ejca.2014.10.002
ISSN1879-0852
AutoresMichel Ducreux, Laétitia Dahan, Denis Smith, Dermot O’Toole, Céline Lepère, Clarisse Dromain, Valérie Vilgrain, Éric Baudin, Catherine Lombard‐Bohas, Jean‐Yves Scoazec, Jean‐François Seitz, Laurence Bitoun, Sébastien Koné, Emmanuel Mitry,
Tópico(s)Lung Cancer Research Studies
Referência(s)